Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activity
Autor: | Anbar, Hanan S., Shehab, Naglaa G., El-Rouby, Nadia M.M., Ansari, Marium A., Chenoth, Haseena, Majeed, Maham, Naeem, Komal, Hersi, Fatima, Omar, Hany A. |
---|---|
Zdroj: | In European Journal of Pharmaceutical Sciences 1 May 2022 172 |
Databáze: | ScienceDirect |
Externí odkaz: |